Viewing Study NCT04636593


Ignite Creation Date: 2025-12-25 @ 12:58 AM
Ignite Modification Date: 2026-01-07 @ 2:32 PM
Study NCT ID: NCT04636593
Status: UNKNOWN
Last Update Posted: 2021-01-12
First Post: 2020-11-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NSCLC
Sponsor:
Organization: